Henrik C. Hansen

Dr. Hansen joined Resverlogix in 2005 and has over 20 years of experience from both academia and industry in basic research, drug discovery and drug development. His areas of expertise include drug discovery, medicinal chemistry. process development and manufacturing of drug substances and drug products under cGMP for clinical use. Dr. Hansen is the inventor of apabetalone (RVX-208). Dr. Hansen holds a M.Sc. in Chemical Engineering from the Technical University of Denmark and a Ph.D. in Organic Chemistry from Lund University, Sweden. He has authored or co- authored more than 70 articles and meeting abstracts and is listed as the inventor of 12 patent families.